Selecting patients for interventional procedures to treat hypertension

References

• Pathak A, Poulter NR, Kavanagh M, et al. Improving the management of hypertension by tackling awareness, adherence, and clinical inertia: a symposium report. Am J Cardiovasc Drugs. 2022;22(3):1–11.
   PubMed Web of Science ®Google Scholar
• Zhou B, Carrillo-Larco RM, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet 2021; 398(10304): 957–980.
   PubMed Web of Science ®Google Scholar
• Azizi M, Sanghvi K, Saxena M, et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397(10293):2476–2486.
   PubMed Web of Science ®Google Scholar
• Azizi M, Schmieder RE, Mahfoud F, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391(10137):2335–2345.
   PubMed Web of Science ®Google Scholar
• Bohm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395(10234):1444–1451.
   PubMed Web of Science ®Google Scholar
• Kandzari DE, Bohm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137):2346–2355.
   PubMed Web of Science ®Google Scholar
• Mahfoud F, Renkin J, Sievert H, et al. Alcohol-Mediated renal denervation using the peregrine system infusion catheter for treatment of hypertension. JACC Cardiovasc Interv. 2020;13(4):471–484.
   PubMed Web of Science ®Google Scholar
• Townsend RR, Mahfoud F, Kandzari DE, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390(10108):2160–2170.
   PubMed Web of Science ®Google Scholar
• Miyajima E, Yamada Y, Yoshida Y, et al. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension. 1991;17(6 Pt 2):1057–1062.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Bosch A. Editorial comment: renal denervation. Hypertens Res. 2022;45(2):241–243.
   PubMed Web of Science ®Google Scholar
• Wei FF, Zhang ZY, Huang QF, et al. Diagnosis and management of resistant hypertension: state of the art. Nat Rev Nephrol. 2018;14(7):428–441.
   PubMed Web of Science ®Google Scholar
• Barbato E, Azizi M, Schmieder RE, et al. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC council on hypertension and the european association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J. 2023;44(15):1313–1330.
   PubMed Web of Science ®Google Scholar
• Fengler K, Rommel KP, Lapusca R, et al. Renal denervation in isolated systolic hypertension using different catheter techniques and technologies. Hypertension. 2019;74(2):341–348.
   PubMed Web of Science ®Google Scholar
• Elmer PJ, Obarzanek E ,Vollmer WM, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomised trial. Ann Intern Med. 2006;144(7):485–495.
   PubMed Web of Science ®Google Scholar
• Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(1):e004473.
   PubMed Web of Science ®Google Scholar
• Arar MY, Hogg RJ ,Arant BS, Jr., Seikaly MG. Aetiology of sustained hypertension in children in the southwestern United States. Pediatr Nephrol. 1994;8(2):186–189.
   PubMed Web of Science ®Google Scholar
• Chetan D, Mertens LL. Challenges in diagnosis and management of coarctation of the aorta. Curr Opin Cardiol. 2022;37(1):115–122.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Hogerl K, Jung S, et al. Patient preference for therapies in hypertension: a cross-sectional survey of german patients. Clin Res Cardiol. 2019;108(12):1331–1342.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Kandzari DE, Wang TD, et al. Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension. J Hypertens. 2021;39(1):162–168.
   PubMed Web of Science ®Google Scholar
• Mancia Chairperson G, Kreutz Co-Chair R, Brunstrom M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023. doi: 10.1097/HJH.0000000000003480.
   PubMedGoogle Scholar
• Mukkamala R, Stergiou GS, Avolio AP. Cuffless blood pressure measurement. Annu Rev Biomed Eng. 2022;24:203–230.
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Palatini P, Parati G, et al. 2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–1302.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71(19):e127–e248.
   PubMed Web of Science ®Google Scholar
• George J, MacDonald T. Home blood pressure monitoring. Eur Cardiol. 2015;10(2):95–101.
   PubMedGoogle Scholar
• Mancia Chairperson G, Kreutz Co-Chair R, Brunström M, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the european society of hypertension endorsed by the european renal association (ERA) and the international society of hypertension (ISH). J Hypertens. 2023. doi: 10.1097/HJH.0000000000003480.
   PubMedGoogle Scholar
• Unger T, Borghi C, Charchar F, et al. 2020 International society of hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–1357.
   PubMed Web of Science ®Google Scholar
• Huang QF, Yang WY, Asayama K, et al. Ambulatory blood pressure monitoring to diagnose and manage hypertension. Hypertension. 2021;77(2):254–264.
   PubMed Web of Science ®Google Scholar
• Conen D, Aeschbacher S, Thijs L, et al. Age-specific differences between conventional and ambulatory daytime blood pressure values. Hypertension. 2014;64(5):1073–1079.
   PubMed Web of Science ®Google Scholar
• Hansen TW, Kikuya M, Thijs L, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25(8):1554–1564.
   PubMed Web of Science ®Google Scholar
• Verdecchia P ,Angeli F ,Borgioni C ,Gattobigio R ,Reboldi G. Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. Hypertension. 2007;49(4):777–783.
   PubMed Web of Science ®Google Scholar
• Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007;356(19):1966–1978.
   PubMed Web of Science ®Google Scholar
• Mente A, O’Donnell MJ, Rangarajan S, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371(7):601–611.
   PubMed Web of Science ®Google Scholar
• O’Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612–623.
   PubMed Web of Science ®Google Scholar
• Sharman JE, Ordunez P, Brady T, et al. 2022 World hypertension league, resolve to save lives and international society of hypertension dietary sodium (salt) global call to action. J Hum Hypertens. 2023;37(2):155–159.
   PubMedGoogle Scholar
• Barroso WKS, Rodrigues CIS, Bortolotto LA, et al. Brazilian guidelines of hypertension - 2020. Arq Bras Cardiol. 2021;116(3):516–658.
   PubMed Web of Science ®Google Scholar
• Joint Committee for Guideline R. Chinese guidelines for prevention and treatment of Hypertension-A report of the revision committee of chinese guidelines for prevention and treatment of hypertension. J Geriatr Cardiol. 2018;16(3):182–241.
   Google Scholar
• Umemura S, Arima H, Arima S, et al. The japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235–1481.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. ESC/ESH guidelines for the management of arterial hypertension. European Heart Journal. 2018;313:603–698.
   Google Scholar
• Kontis V, Cobb LK, Mathers CD, et al. Three public health interventions could save 94 million lives in 25 years. Circulation. 2019;140(9):715–725.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Fahimi S, Singh GM, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371(7):624–634.
   PubMed Web of Science ®Google Scholar
• Pilic L, Pedlar CR, Mavrommatis Y. Salt-sensitive hypertension: mechanisms and effects of dietary and other lifestyle factors. Nutr Rev. 2016;74(10):645–658.
   PubMed Web of Science ®Google Scholar
• Rust P ,Ekmekcioglu C. Impact of salt intake on the pathogenesis and treatment of hypertension. Adv Exp Med Biol. 2017;956:61–84.
   PubMed Web of Science ®Google Scholar
• Holbrook JT ,Patterson KY ,Bodner JE, et al. Sodium and potassium intake and balance in adults consuming self-selected diets. Am J Clin Nutr. 1984;40(4):786–793.
   PubMed Web of Science ®Google Scholar
• Maughan RJ ,Leiper JB. Sodium intake and post-exercise rehydration in man. Eur J Appl Physiol Occup Physiol. 1995;71(4): 311–319.
   PubMed Web of Science ®Google Scholar
• Omboni S, McManus RJ, Bosworth HB, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension. 2020;76(5):1368–1383.
   PubMed Web of Science ®Google Scholar
• Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124–1140.
   PubMed Web of Science ®Google Scholar
• Antoniou S, Saxena M, Hamedi N, et al. Management of hypertensive patients with multiple drug intolerances: a Single-Center experience of a novel treatment algorithm. J Clin Hypertens (Greenwich). 2016;18(2):129–138.
   PubMed Web of Science ®Google Scholar
• Burnier M ,Egan BM. Adherence in hypertension. Circul Res. 2019;124(7):1124–1140.
   PubMed Web of Science ®Google Scholar
• Tanna S ,Ogwu J ,Lawson G. Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives. Clin Chem Lab Med 2020;58(5):643–663.
   PubMed Web of Science ®Google Scholar
• Azizi M ,Pereira H ,Hamdidouche I, et al. Adherence to antihypertensive treatment and the blood pressure lowering effects of renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial. Circulation. 2016;134(12):847–857.
   PubMed Web of Science ®Google Scholar
• Glynn LG ,Murphy AW ,Smith SM ,Schroeder K ,Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev 2010;3:CD005182.
   Google Scholar
• Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55(2):399–407.
   PubMed Web of Science ®Google Scholar
• Verma AA, Khuu W, Tadrous M, et al. Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: a population-based retrospective cohort study. PLoS Med. 2018;15(6):e1002584.
   PubMed Web of Science ®Google Scholar
• Webster R, Murphy A, Bygrave H, et al. Implementing fixed dose combination medications for the prevention and control of cardiovascular diseases. Glob Heart. 2020;15(1):57.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
   PubMed Web of Science ®Google Scholar
• Herrmann SM, Textor SC. Renovascular hypertension. Endocrinol Metab Clin North Am. 2019;48(4):765–778.
   PubMed Web of Science ®Google Scholar
• Baumgartner I, Lerman LO. Renovascular hypertension: screening and modern management. Eur Heart J. 2011;32(13):1590–1598.
   PubMed Web of Science ®Google Scholar
• Textor SC. Pitfalls in imaging for renal artery stenosis. Ann Intern Med 2004;141(9):730–731.
   PubMed Web of Science ®Google Scholar
• Gornik HL ,Persu A ,Adlam D, et al. First international consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med 2019;24(2):164–189.
   PubMed Web of Science ®Google Scholar
• Fodor L ,Premuzic V ,Ivkovic V, et al. Arterial stiffness in atherosclerotic renovascular hypertension. J Hypertens. 2014;32(11):2238–2245; discussion 45.
   PubMed Web of Science ®Google Scholar
• Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomised trial. Ann Intern Med. 2009;150(12):840–888, W150-1.
   PubMed Web of Science ®Google Scholar
• Investigators A ,Wheatley K, Ives N, et al. Revascularization versus medical therapy for renal-artery stenosis. New Engl J Med. 2009;361(20):1953–1962.
   PubMed Web of Science ®Google Scholar
• Schmieder RE. Renal denervation in patients with chronic kidney disease: current evidence and future perspectives. Nephrol Dial Transplant. 2023;38(5):1089–1096.
   PubMed Web of Science ®Google Scholar
• Zennaro MC, Boulkroun S ,Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol 2020;16(10):578–589.
   PubMed Web of Science ®Google Scholar
• Nishioka H ,Yamada S. Cushing’s disease. J Clin Med 2019;8(11):1951.
   PubMed Web of Science ®Google Scholar
• Medical Masterclass C ,Firth J. Endocrinology: phaeochromocytoma. Clin Med. 2019;19(1):68–71.
   PubMed Web of Science ®Google Scholar
• Kayser SC, Dekkers T, Groenewoud HJ, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and Meta-Regression analysis. J Clin Endocrinol Metab. 2016;101(7):2826–2835.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Monticone S, Deinum J, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the european society of hypertension. J Hypertens. 2020;38(10):1919–1928.
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol. 2016;101(5):1889–1916.
   PubMed Web of Science ®Google Scholar
• Calhoun DA. Hyperaldosteronism as a common cause of resistant hypertension. Annu Rev Med. 2013;64:233–247.
   PubMed Web of Science ®Google Scholar
• Schilbach K ,Junnila RK ,Bidlingmaier M. Aldosterone to renin ratio as screening tool in primary aldosteronism. Exp Clin Endocrinol Diabetes. 2019;127(2-03):84–92.
   PubMed Web of Science ®Google Scholar
• Kebebew E. Adrenal incidentaloma. New Engl J Med. 2021;384(16):1542–1551.
   PubMed Web of Science ®Google Scholar
• Jinchai J, Khamsai S, Chattakul P, et al. How common is obstructive sleep apnea in young hypertensive patients? Intern Emerg Med. 2020;15(6):1005–1010.
   PubMed Web of Science ®Google Scholar
• Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271–2277.
   PubMed Web of Science ®Google Scholar
• Brown J, Yazdi F, Jodari-Karimi M, et al. Obstructive sleep apnea and hypertension: updates to a critical relationship. Curr Hypertens Rep. 2022;24(6):173–184.
   PubMed Web of Science ®Google Scholar
• Corral J, Sanchez-Quiroga MA, Carmona-Bernal C, et al. Conventional polysomnography is not necessary for the management of most patients with suspected obstructive sleep apnea. Noninferiority, randomized controlled trial. Am J Respir Crit Care Med. 2017;196(9):1181–1190.
   PubMed Web of Science ®Google Scholar
• Malhotra A ,White DP. Obstructive sleep apnoea. Lancet 2002;360(9328):237–245.
   PubMed Web of Science ®Google Scholar
• Hla KM ,Young T ,Finn L, et al. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study. Sleep 2008;31(6):795–800.
   PubMed Web of Science ®Google Scholar
• Warchol-Celinska E, Prejbisz A, Kadziela J, et al. Renal denervation in resistant hypertension and obstructive sleep apnea: randomized proof-of-Concept phase II trial. Hypertension. 2018;72(2):381–390.
   PubMed Web of Science ®Google Scholar
• Xu W, Goldberg SI, Shubina M, et al. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ. 2015;350:h158.
   PubMedGoogle Scholar
• Fatani N, Dixon DL, Van Tassell BW, et al. Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol. 2021;77(10):1290–1299.
   PubMed Web of Science ®Google Scholar